Peijia Medical Ltd
HKEX:9996
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2.25
8.15
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Peijia Medical Ltd
Cash from Operating Activities
Peijia Medical Ltd
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
P
|
Peijia Medical Ltd
HKEX:9996
|
Cash from Operating Activities
-ÂĄ583.5m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-72%
|
CAGR 10-Years
N/A
|
|
A
|
APT Medical Inc
SSE:688617
|
Cash from Operating Activities
ÂĄ689.1m
|
CAGR 3-Years
67%
|
CAGR 5-Years
106%
|
CAGR 10-Years
N/A
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Cash from Operating Activities
ÂĄ1.8B
|
CAGR 3-Years
9%
|
CAGR 5-Years
26%
|
CAGR 10-Years
28%
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Cash from Operating Activities
ÂĄ14.4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
||
J
|
Jafron Biomedical Co Ltd
SZSE:300529
|
Cash from Operating Activities
ÂĄ1.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Cash from Operating Activities
ÂĄ132.5m
|
CAGR 3-Years
-66%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Peijia Medical Ltd
Glance View
Peijia Medical Ltd. engages in the manufacture and sale of medical devices. The company is headquartered in Suzhou, Jiangsu. The company went IPO on 2020-05-15. Through its subsidiaries, the Company operates two segments. Transcatheter Valve Therapeutic Business segment is mainly engaged in the development of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is engaged in the research and development of neurointerventional procedural medical devices. The firm's main products under development include TaurusOne, TaurusElite, TaurusNXT and others. The firm operates its businesses primarily in domestic market.
See Also
What is Peijia Medical Ltd's Cash from Operating Activities?
Cash from Operating Activities
-583.5m
CNY
Based on the financial report for Dec 31, 2023, Peijia Medical Ltd's Cash from Operating Activities amounts to -583.5m CNY.
What is Peijia Medical Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-72%
Over the last year, the Cash from Operating Activities growth was -55%. The average annual Cash from Operating Activities growth rates for Peijia Medical Ltd have been -48% over the past three years , -72% over the past five years .